盘龙药业：2025年上半年净利润6013.52万元，同比增长0.81%

Group 1 - The core point of the article is that Panlong Pharmaceutical reported a revenue of 574 million yuan for the first half of 2025, representing a year-on-year growth of 26.06% [1] - The net profit for the same period was 60.1352 million yuan, showing a slight increase of 0.81% year-on-year [1] - The company plans to distribute a cash dividend of 1 yuan (including tax) for every 10 shares based on a total of 106 million shares to all shareholders [1]